258 related articles for article (PubMed ID: 17574288)
1. Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.
Blanco E; Bey EA; Dong Y; Weinberg BD; Sutton DM; Boothman DA; Gao J
J Control Release; 2007 Oct; 122(3):365-74. PubMed ID: 17574288
[TBL] [Abstract][Full Text] [Related]
2. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
[TBL] [Abstract][Full Text] [Related]
3. β-Lapachone and Paclitaxel Combination Micelles with Improved Drug Encapsulation and Therapeutic Synergy as Novel Nanotherapeutics for NQO1-Targeted Cancer Therapy.
Zhang L; Chen Z; Yang K; Liu C; Gao J; Qian F
Mol Pharm; 2015 Nov; 12(11):3999-4010. PubMed ID: 26415823
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology-enabled delivery of NQO1 bioactivatable drugs.
Ma X; Moore ZR; Huang G; Huang X; Boothman DA; Gao J
J Drug Target; 2015; 23(7-8):672-80. PubMed ID: 26453163
[TBL] [Abstract][Full Text] [Related]
5. Intermolecular Interactions between Coencapsulated Drugs Inhibit Drug Crystallization and Enhance Colloidal Stability of Polymeric Micelles.
Zhang L; Sun H; Chen Z; Liu Z; Huang N; Qian F
Mol Pharm; 2017 Oct; 14(10):3568-3576. PubMed ID: 28829143
[TBL] [Abstract][Full Text] [Related]
6. Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.
Ma X; Huang X; Huang G; Li L; Wang Y; Luo X; Boothman DA; Gao J
Adv Healthc Mater; 2014 Aug; 3(8):1210-6. PubMed ID: 24532286
[TBL] [Abstract][Full Text] [Related]
7. Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy.
Blanco E; Bey EA; Khemtong C; Yang SG; Setti-Guthi J; Chen H; Kessinger CW; Carnevale KA; Bornmann WG; Boothman DA; Gao J
Cancer Res; 2010 May; 70(10):3896-904. PubMed ID: 20460521
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
[TBL] [Abstract][Full Text] [Related]
9. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
[TBL] [Abstract][Full Text] [Related]
10. Assessment of various formulation approaches for the application of beta-lapachone in prostate cancer therapy.
Wu X; Kasselouri A; Vergnaud-Gauduchon J; Rosilio V
Int J Pharm; 2020 Apr; 579():119168. PubMed ID: 32087264
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.
Choi EK; Terai K; Ji IM; Kook YH; Park KH; Oh ET; Griffin RJ; Lim BU; Kim JS; Lee DS; Boothman DA; Loren M; Song CW; Park HJ
Neoplasia; 2007 Aug; 9(8):634-42. PubMed ID: 17786182
[TBL] [Abstract][Full Text] [Related]
12. Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-Lapachone delivery.
Zhou Y; Dong Y; Huang G; Wang Y; Huang X; Zhang F; Boothman DA; Gao J; Liang W
J Mater Chem B; 2016 Dec; 4(46):7429-7440. PubMed ID: 28580145
[TBL] [Abstract][Full Text] [Related]
13. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
[TBL] [Abstract][Full Text] [Related]
14. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.
Li LS; Bey EA; Dong Y; Meng J; Patra B; Yan J; Xie XJ; Brekken RA; Barnett CC; Bornmann WG; Gao J; Boothman DA
Clin Cancer Res; 2011 Jan; 17(2):275-85. PubMed ID: 21224367
[TBL] [Abstract][Full Text] [Related]
15. Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein.
Dong GZ; Youn H; Park MT; Oh ET; Park KH; Song CW; Choi EK; Park HJ
Int J Hyperthermia; 2009; 25(6):477-87. PubMed ID: 19657853
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1.
Terai K; Dong GZ; Oh ET; Park MT; Gu Y; Song CW; Park HJ
Anticancer Drugs; 2009 Nov; 20(10):901-9. PubMed ID: 19738461
[TBL] [Abstract][Full Text] [Related]
17. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
[TBL] [Abstract][Full Text] [Related]
18. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
19. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage.
Su X; Wang J; Jiang L; Chen Y; Lu T; Mendonca MS; Huang X
Cancer Lett; 2021 Oct; 519():304-314. PubMed ID: 34329742
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy.
Kumari P; Muddineti OS; Rompicharla SV; Ghanta P; B B N AK; Ghosh B; Biswas S
Drug Deliv; 2017 Nov; 24(1):209-223. PubMed ID: 28156164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
